Skip to content

Drug interactions

Eltrombopag + Sulphasalazine

Severity: Moderate

Eltrombopag and Sulphasalazine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eltrombopag inhibits breast cancer resistance protein (BCRP) and can raise exposure to BCRP substrates such as sulfasalazine. Higher sulfasalazine levels may increase dose-related adverse effects, including nausea, headache and rash.

What this interaction means in plain words

Eltrombopag and Sulphasalazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eltrombopag belongs to Miscellaneous; Sulphasalazine belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

Inhibition of intestinal BCRP efflux transport by eltrombopag, increasing sulfasalazine absorption.

What to do

Monitor for sulfasalazine adverse effects and consider a lower dose if intolerance develops. Review blood counts and liver tests as usual for sulfasalazine.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eltrombopag and Sulphasalazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eltrombopag with Sulphasalazine?

MediHelp rates the interaction as moderate. Eltrombopag and Sulphasalazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eltrombopag inhibits breast cancer resistance protein (BCRP) and can raise exposure to BCRP substrates such as sulfasalazine. Higher sulfasalazine levels may increase dose-related adverse effects, including nausea, headache and rash.

How serious is the interaction between Eltrombopag and Sulphasalazine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for sulfasalazine adverse effects and consider a lower dose if intolerance develops. Review blood counts and liver tests as usual for sulfasalazine.

What other medicines interact with Sulphasalazine?

MediHelp also lists interactions of Sulphasalazine with, for example, Deferiprone, Pexidartinib, Sepiapterin. The full list is on the Sulphasalazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in